Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice (Q45306085)

11 December 2017

title

Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice (English)

1 reference

11 December 2017

0 references

A Wallace Deckel

1

1 reference

11 December 2017

Vinsee Tang

2

1 reference

11 December 2017

Diane Nuttal

3

1 reference

11 December 2017

Keith Gary

4

1 reference

11 December 2017

Robert Elder

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

11 December 2017

1 reference

11 December 2017

volume

939

1 reference

11 December 2017

issue

1-2

1 reference

11 December 2017

page(s)

76-86

1 reference

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

High blood levels of nitric oxide in rats subjected to prolonged respiratory arrest and their modulation during adrenocorticotropin-induced resuscitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Sustained attenuation of the cerebrovascular response to a 10 min whisker stimulation following neuronal nitric oxide synthase inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Endogenous nitric oxide synthesis: biological functions and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide in neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide and nitric oxide synthase in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Mechanisms of cell death governed by the balance between nitrosative and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Selective sparing of a class of striatal neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Regulation of neuronal nitric-oxide synthase by calmodulin kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Plasticity of NO synthase expression in the nervous and endocrine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Nitric oxide synthase-independent generation of nitric oxide in rat skeletal muscle ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntington's disease. Pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Inhibition by calmodulin antagonists of the neurogenic relaxation in cerebral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

The CaM-kinase II inhibitor KN-62 blocks NMDA but not kainate stimulation of NO synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Hypoxia influences enkephalin release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

7 January 2021

Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Antioxidant effects of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Pathology of CAG repeat diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Modulation of LTP induction by NMDA receptor activation and nitric oxide release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

Oxidative stress in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902550-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(02)02550-7

1 reference

11 December 2017

1 reference